City

Columbus (1)

Houston (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Ohio State University Comprehensive Cancer Center (1)

Collaborator

Clovis Oncology, Inc. (1)

ImmunoGen, Inc. (1)

National Cancer Institute (NCI) (1)

Intervention

mirvetuximab soravtansine (2)

laboratory biomarker analysis (1)

pharmacokinetic study (1)

rucaparib camsylate (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

folate receptor alpha positive

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting

BRCA1 Gene Mutation
+9 more

Laboratory Biomarker Analysis
+3 more

Columbus, Ohio

Ohio State University Comprehensive Cancer Center

Sep 16, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Completed

Has Results

Anatomic Stage II Breast Cancer AJCC v8
+20 more

Mirvetuximab Soravtansine

Houston, Texas

M D Anderson Cancer Center

Nov 18, 2020